Entera Bio Ltd.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Entera Bio Ltd. is publicly traded on NASDAQ under the ticker ENTX.
Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is...
Can you invest in Entera Bio Ltd.?
Yes. Entera Bio Ltd. trades publicly on NASDAQ as ENTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Entera Bio Ltd.
Detailed equity research is provided by MarketSnap.